适应性进化,具有增强的形式耐受性和其在3-基酸生产中的应用
Xuhua Mo1, Yan Zhao1, Lin Zhu1
1School of Life Sciences, Shandong Province Key Laboratory of Applied Mycology, and Qingdao International Center on Microbes Utilizing Biogas, Qingdao Agricultural University, Qingdao, Shandong, People's Republic of China.
Applied and environmental microbiology
|August 13, 2025
概括
研究人员使用适应性实验室进化技术设计了Methylorubrum extorquens AM1以创建FT3菌株,该菌株表现出显著增强的形成耐受性. 这种进化的菌株有效地共同利用甲醇和甲酸盐,为改善生物生产铺平了道路.
科学领域:
- 微生物生物技术 微生物生物技术
- 合成生物学 合成生物学
- 代谢工程是代谢工程.
背景情况:
- 甲基除 AM1自然利用形式但表现出有限的耐受性.
- 增强的酸盐耐受性对于在微生物过程中高效地共同利用甲醇和酸盐至关重要.
- 适应性实验室进化 (ALE) 是改善微生物特征的强大策略.
研究的目的:
- 使用ALE.开发一种M. extorquens AM1的形式耐受菌株.
- 阐明增强格式耐受性背后的机制.
- 评估进化菌株在生产有价值化学品方面的潜力.
主要方法:
- 适应性实验室进化 (ALE) 的M. extorquens AM1.
- 高通量选和使用混合碳来源 (格式和甲醇) 的栽培.
- 基因组重新测序,转录组分析和基因操纵实验.
- 用于生产3-基酸 (3-HP) 的料批发发酵.
主要成果:
- 一个进化的菌株,FT3,在成型和甲醇上生长时,与父菌株相比,光密度增加了5.3倍.
- FT3被确定为一种超级突变物,具有增强的形式耐受性,归因于增强的形式运输,改进的甲醇氧化和增强的形式氧化/同化途径.
- 过度表达特定的基因 (META1_0287*,META1_3027,META1_3028,META1_3029,META1_1261,META1_1418,META1_2965) 证实了它们在形式耐受性中的作用.
- FT3菌株显示NADH和NADPH的生成得到了改善,并实现了2.47g/L的3HP产量.
结论:
- 通过改善甲醇和甲酸盐的共同利用,ALE成功生成了耐酸盐的M. extorquens菌株 (FT3).
- 该研究确定了促进增强形式耐受性的关键遗传和代谢机制.
- 经过工程设计的FT3菌株作为一个有前途的底盘,可以有效地生产像3-HP.这样的减少化学品.
相关概念视频
03:08Hydroboration-Oxidation of Alkenes
10.1K
In addition to the oxymercuration–demercuration method, which converts the alkenes to alcohols with Markovnikov orientation, a complementary hydroboration-oxidation method yields the anti-Markovnikov product. The hydroboration reaction, discovered in 1959 by H.C. Brown, involves the addition of a B–H bond of borane to an alkene giving an organoborane intermediate. The oxidation of this intermediate with basic hydrogen peroxide forms an alcohol.
10.1K
01:22Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
01:27Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
01:25Production of Organic Acids
105
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
105
01:30Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94